Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,177,788 papers from all fields of science
Search
Sign In
Create Free Account
Immunogenicity Study
Known as:
IMMUNOGENICITY
A study that assesses an agent's ability to provoke an immune response (humoral and/or cell-mediated) in the subject.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CDISC SDTM Trial Type Terminology
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Kapil Bahl
,
Joe J. Senn
,
+11 authors
G. Ciaramella
Molecular Therapy
2017
Corpus ID: 4422665
Review
2017
Review
2017
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
Ward Fleri
,
S. Paul
,
+4 authors
A. Sette
Frontiers in Immunology
2017
Corpus ID: 6159715
The task of epitope discovery and vaccine design is increasingly reliant on bioinformatics analytic tools and access to…
Expand
Highly Cited
2017
Highly Cited
2017
Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells
Xiaohua Zhu
,
M. Badawi
,
+10 authors
M. Phelps
Journal of Extracellular Vesicles
2017
Corpus ID: 22825964
ABSTRACT Extracellular vesicles (EVs) are under evaluation as therapeutics or as vehicles for drug delivery. Preclinical studies…
Expand
Review
2016
Review
2016
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation.
P. Zhang
,
Fang Sun
,
Sijun Liu
,
Shaoyi Jiang
Journal of Controlled Release
2016
Corpus ID: 205880620
Highly Cited
2016
Highly Cited
2016
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
K. Gecse
,
B. Lovász
,
+21 authors
P. Lakatos
Journal of Crohn's & Colitis
2016
Corpus ID: 32151539
BACKGROUND AND AIMS Biosimilar infliximab CT-P13 is approved for all indications of the originator product in Europe. Prospective…
Expand
Review
2016
Review
2016
Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application.
K. Hussein
,
Kyung-Mee Park
,
Kyung-Sun Kang
,
H. Woo
Materials Science and Engineering C: Materials…
2016
Corpus ID: 34819583
Highly Cited
2016
Highly Cited
2016
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.
J. Regules
,
Susan B Cicatelli
,
+33 authors
J. Vekemans
Journal of Infectious Diseases
2016
Corpus ID: 20938073
BACKGROUND Three full doses of RTS,S/AS01 malaria vaccine provides partial protection against controlled human malaria parasite…
Expand
Review
2015
Review
2015
Vaccine Adjuvants: from 1920 to 2015 and Beyond
A. Di Pasquale
,
S. Preiss
,
F. Tavares Da Silva
,
N. Garçon
Vaccines
2015
Corpus ID: 2193437
The concept of stimulating the body’s immune response is the basis underlying vaccination. Vaccines act by initiating the innate…
Expand
Highly Cited
2015
Highly Cited
2015
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes
D. Chowell
,
S. Krishna
,
+7 authors
K. Anderson
Proceedings of the National Academy of Sciences
2015
Corpus ID: 11066665
Significance The design of effective T-cell vaccines against pathogens and tumor antigens is challenged by the highly inefficient…
Expand
Highly Cited
2014
Highly Cited
2014
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
P. Naud
,
C. Roteli-Martins
,
+7 authors
D. Descamps
Human Vaccines & Immunotherapeutics
2014
Corpus ID: 18198515
HPV-023 (NCT00518336; ClinicalTrial.gov) is a long-term follow-up of an initial double-blind, randomized (1:1), placebo…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE